全文获取类型
收费全文 | 6028篇 |
免费 | 540篇 |
国内免费 | 125篇 |
专业分类
耳鼻咽喉 | 165篇 |
儿科学 | 330篇 |
妇产科学 | 141篇 |
基础医学 | 709篇 |
口腔科学 | 152篇 |
临床医学 | 686篇 |
内科学 | 1140篇 |
皮肤病学 | 94篇 |
神经病学 | 412篇 |
特种医学 | 540篇 |
外国民族医学 | 1篇 |
外科学 | 797篇 |
综合类 | 249篇 |
预防医学 | 484篇 |
眼科学 | 181篇 |
药学 | 379篇 |
中国医学 | 3篇 |
肿瘤学 | 230篇 |
出版年
2021年 | 76篇 |
2020年 | 53篇 |
2019年 | 99篇 |
2018年 | 109篇 |
2017年 | 74篇 |
2016年 | 89篇 |
2015年 | 106篇 |
2014年 | 121篇 |
2013年 | 189篇 |
2012年 | 228篇 |
2011年 | 255篇 |
2010年 | 175篇 |
2009年 | 188篇 |
2008年 | 249篇 |
2007年 | 269篇 |
2006年 | 259篇 |
2005年 | 247篇 |
2004年 | 199篇 |
2003年 | 182篇 |
2002年 | 180篇 |
2001年 | 181篇 |
2000年 | 206篇 |
1999年 | 180篇 |
1998年 | 156篇 |
1997年 | 152篇 |
1996年 | 174篇 |
1995年 | 108篇 |
1994年 | 113篇 |
1993年 | 109篇 |
1992年 | 118篇 |
1991年 | 119篇 |
1990年 | 111篇 |
1989年 | 134篇 |
1988年 | 116篇 |
1987年 | 124篇 |
1986年 | 112篇 |
1985年 | 129篇 |
1984年 | 88篇 |
1983年 | 66篇 |
1982年 | 76篇 |
1981年 | 57篇 |
1980年 | 61篇 |
1979年 | 54篇 |
1978年 | 52篇 |
1977年 | 54篇 |
1976年 | 60篇 |
1975年 | 60篇 |
1974年 | 42篇 |
1973年 | 32篇 |
1968年 | 44篇 |
排序方式: 共有6693条查询结果,搜索用时 31 毫秒
41.
42.
Accumulation of arsenic and zinc in the rhizosphere of wetland plants 总被引:12,自引:0,他引:12
43.
Vivek N Ahya Alden M Doyle James D Mendez David A Lipson Jason D Christie Emily A Blumberg Alberto Pochettino Linda Nelson Roy D Bloom Robert M Kotloff 《The Journal of heart and lung transplantation》2005,24(7):932-935
Chronic rejection is the major hurdle to long-term survival after lung transplantation. Endobronchial infection with Pseudomonas aeruginosa is common in patients with chronic rejection and this may further contribute to deterioration of the allograft. Inhaled tobramycin is commonly used to treat P aeruginosa airways infection in patients with cystic fibrosis. The safety of inhaled tobramycin in transplant recipients, however, has not been established. We describe the first report of a lung transplant recipient who developed renal failure and vestibular injury after receiving inhaled tobramycin. We review the literature regarding the safety of inhaled tobramycin and discuss potential mechanisms that may promote systemic toxicity in transplant recipients. 相似文献
44.
Ingi Lee Todd D. Barton Simin Goral Alden M. Doyle Roy D. Bloom Donna Chojnowski Kathleen Korenda Emily A. Blumberg 《American journal of transplantation》2005,5(11):2791-2795
Dapsone, used for prevention of Pneumocystis jirovecii infections, has been reported to cause hemolytic anemia and methemoglobinemia; its tolerability in solid organ transplant recipients is not well described. We investigated dapsone-related adverse events in patients undergoing solid organ transplantation from 1999 to 2004. Transplant providers identified patients for the investigators who then reviewed the patients' hospital and outpatient records. Sixteen solid organ transplant recipients fit case definitions for dapsone-related hemolytic anemia (n = 11) or methemoglobinemia (n = 5). Median time from event to dapsone discontinuation was 15 days; all patients improved after drug discontinuation. G6PD enzyme activity was normal in all patients whose test results were available. Dapsone may be associated with hemolytic anemia or methemoglobinemia, even with normal G6PD levels. These events are often not promptly recognized, and drug discontinuation is delayed. Dapsone-related hemolytic anemia or methemoglobinemia should be considered in solid organ transplant recipients with unexplained anemia or hypoxia. 相似文献
45.
Having read the introduction, I had high hopes for this secondedition of the Anaesthetic Aide Memoire. Not too weighty andof a size that would fit into the pocket of a white coat (ormore appropriately theatre blues). In their introduction, theauthors set out their stall by saying it is a compilation oflists and diagrams to be used as a ready reference for bothsenior trainees and consultants. They see it as a useful aidto teaching and 相似文献
46.
47.
R Mokni A Chakar F Bleiberg-Daniel JL Mahu PA Walravens P Chappuis J Navarro D Lemonnier 《Acta paediatrica (Oslo, Norway : 1992)》1993,82(6-7):539-543
Biochemical markers of nutritional status (albumin, transthyretin, insulin-like growth factor-I and zinc) were measured in slowly growing two- to five-year-old, low-income Parisian children whose weight-for-height or height-for-age z scores (WHZ or HAZ) were between — 1 and — 2 SD of the NCHS median. The results were compared to controls who were matched for age, sex, and ethnic origin with WHZ and HAZ between — 1 and + 2 SD. Mean serum levels of transthyretin, albumin and insulin-like growth factor-I and mean plasma zinc concentrations were significantly lower in the growth-impaired children than in the controls ( p = 0.002, p = 0.006, p = 0.015, and p = 0.035, respectively). While the height-retarded children had low mean serum insulin-like growth factor-I values, the weight-retarded subjects had decreased levels of albumin, transthyretin and zinc when compared to controls. Lower mean levels of nutritional markers in healthy, slowly growing children suggest that inadequate dietary intakes of zinc, protein and/or energy may result in marginal delays in weight and height gains. 相似文献
48.
JI Elizalde ; J Clemente ; JL Marin ; J Panes ; B Aragon ; A Mas ; JM Pique ; J Teres 《Transfusion》1997,37(6):573-576
BACKGROUND: Equilibration of hemoglobin concentration after transfusion has been estimated to take about 24 hours, but some studies have shown that earlier measurements reflect steady-state values in persons who have not bled recently. This study was aimed at assessing the changes over time in hemoglobin concentration after transfusion in acutely anemic patients because of recent bleeding. STUDY DESIGN AND METHODS: Thirty-two normovolemic patients recovering from an acute bleeding episode who were no longer thought to be bleeding and who received a 2- unit red cell transfusion were studied. At baseline and 15, 30, 60, and 120 minutes and 24 hours after transfusion, hemoglobin concentration and hematocrit values were measured. RESULTS: The administration of 2 units of packed red cells elicited a 24-hour increase of 22.4 +/− 6.8 g per L in hemoglobin concentration. Hemoglobin values were not different at any of the defined posttransfusion times. Hematocrit levels experienced similar changes over time. Agreement between 15-minute and 24-hour values was excellent, as only 6 percent of patients exhibited a clinically significant difference (> 6 g/L) between the hemoglobin measurements. CONCLUSION: Hemoglobin and hematocrit values rapidly equilibrate after transfusion in normovolemic patients who are recovering from an acute bleeding episode. This fact would allow a rapid assessment of the effects of transfusion and of the recurrence of bleeding in patients remaining at risk. 相似文献
49.
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Annals of surgery》网站下载免费的PDF全文](/ch/ext_images/free.gif)
S Todo J J Fung T E Starzl A Tzakis H Doyle K Abu-Elmagd A Jain R Selby O Bronsther W Marsh et al. 《Annals of surgery》1994,220(3):297-309
OBJECTIVE: The efficacy for primary orthotopic liver transplantation of a new immunosuppressive agent, FK 506 (tacrolimus, Prograf, Fujisawa USA, Deerfield, IL), was determined. SUMMARY BACKGROUND DATA: After 3 years of preclinical research, a clinical trial of FK 506 for orthotopic liver transplantation was begun in February 1989, first as a rescue therapy for patients with intractable rejection with conventional immunosuppression, then as a primary drug. METHODS: Between August 1989 and December 1993, 1391 recipients (1188 adult and 203 pediatric) of primary liver allografts were treated with FK 506 from the outset. Results from these patients were analyzed and compared with those of 1212 historical control patients (971 adult and 241 pediatric) given cyclosporine-based immunosuppression. RESULTS: Actuarial survival at 4 years was 86.2% with FK 506 versus 65.5% with cyclosporine in the pediatric patients (p < 0.0000) and 71.4% versus 65.5% in the adults (p < 0.0005). The need for retransplantation was reduced significantly for FK 506 patients. Four-year graft survival was 77.0% with FK 506 versus 48.4% with cyclosporine in the pediatric patients (p < 0.0000), and 61.9% with FK 506 versus 51.4% with cyclosporine in the adult recipients (p < 0.0000). Regression analysis revealed that reduction in mortality or graft loss from uncontrollable rejection, sepsis, technical failure, and recurrent original liver disease were responsible for the improved results with FK 506 therapy. CONCLUSIONS: FK 506 is a potent and superior immunosuppressive agent for orthotopic liver transplantation. 相似文献
50.
Selective laser trabeculoplasty in phakic and pseudophakic eyes. 总被引:2,自引:0,他引:2
BACKGROUND AND OBJECTIVE: To evaluate the effect of pseudophakia on the success of selective laser trabeculoplasty in lowering intraocular pressure (IOP). PATIENTS AND METHODS: In this retrospective, nonrandomized clinical trial, a chart review of all patients who underwent selective laser trabeculoplasty from September 2002 to June 2004 using a frequency-doubled Q-switched 532-nm Nd:YAG laser was performed. Changes in IOP and statistical significance were determined at each follow-up period. Average decrease in IOP and success rates for phakic and pseudophakic eyes were compared statistically at each time period. RESULTS: In the phakic group, mean IOP decreased from 18.1 to 15.5 mm Hg (P < .0005) and mean glaucoma medication use decreased from 2.1 to 1.6 medications after 24 months of follow-up. In the pseudophakic group, mean IOP decreased from 18.3 to 15.2 mm Hg (P < .005) and mean glaucoma medication use decreased from 2.2 to 1.6 medications. Success rates ranged from 54% to 67% in the phakic group and 52% to 65% in the pseudophakic group. No statistically significant difference between phakic and pseudophakic eyes in decreased IOP or success rates was seen at any time point (P > .05). No significant complications occurred in either group. CONCLUSIONS: Selective laser trabeculoplasty is effective in lowering IOP in both phakic and pseudophakic patients. 相似文献